Chembond Chemicals
- Market cap
- ₹ 646 Cr.
- P/E
- 15.3x
- P/B
- 3.29x
- 52-week range
- 104.85 – 290
- ROE
- 18%
- ROCE
- 24%
- Dividend yield
- 0.5%
- Debt / equity
- 0
- Sector
- Chemicals & Petrochemicals
- Industry
- Specialty Chemicals
- Listed on
- NSE, BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Specialty Chemicals: 130 companies →Chembond Chemicals against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)15.3 against a typical 25.8: cheaper than most peers (1st = cheapest).38th of 129
- Sales growth+31.1% against a typical +25.9% from a year earlier.45th of 112
- Profit growth−54.7% against a typical +42.4% from a year earlier.95th of 102
- Share price, 3 months−1.5% against a typical −5.8%.51st of 118
- Size₹ 646.1 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).56th of 126
Latest announcements
Exchange filings and their impact on the company.
- 24 Oct 2026Investor PresentationHigh impactPositiveH1 sales jumped 32% to Rs 182 cr but profits were flat as raw-material costs squeezed margins.
Chembond Chemicals shared its H1 FY27 investor presentation for the quarter and half year ended September 2026. Consolidated H1 revenue was Rs 182.25 crores, up 32% year-on-year, with strong growth in Water Technologies, Construction Chemicals, Distribution and Cleaning & Hygiene. Consolidated EBITDA was Rs 22.55 crores and PBT was Rs 19.79 crores, both up only 2%, as volatile raw-material costs hurt margins, though the company said the revenue outlook remains positive.
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 24 Oct 2026 | Financial Results | To consider and approve the Unaudited financial results for the period ended September 30, 2026 |
| 16 Jul 2026 | Financial Results | To consider and approve the Un-Audited financial results for the period ended Jun 30, 2026 |
| 16 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend if any |
| 21 Jan 2026 | Financial Results | To consider and approve the Unaudited financial results for the period ended December 31, 2025 |
| 16 Oct 2025 | Financial Results | To consider and approve the unaudited Standalone & Consolidated financial results for the period ended September 30, 2025 |
| 26 Jul 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 64 | 75 | 75 | 78 | 65 | 73 | 86 | 101 | 86 | 96 |
| Expenses | 57 | 67 | 60 | 66 | 57 | 62 | 74 | 86 | 75 | 87 |
| Operating Profit | 7 | 8 | 14 | 12 | 8 | 11 | 12 | 16 | 11 | 8 |
| OPM % | 11.4% | 10.5% | 19.2% | 15.7% | 12.9% | 14.6% | 14.3% | 15.7% | 13.1% | 8.7% |
| Other Income | 2 | 2 | 0 | 2 | 3 | 0 | 1 | −0 | 3 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 |
| Profit before tax | 8 | 9 | 13 | 12 | 10 | 10 | 12 | 14 | 13 | 7 |
| Tax % | 30.7% | 24.1% | 25.7% | 25.1% | 36% | 25.2% | 18.5% | 16.7% | 25.3% | 53.5% |
| Net Profit | 6 | 7 | 10 | 9 | 6 | 7 | 10 | 12 | 10 | 3 |
| EPS in Rs | — | — | — | — | 2.33 | 2.7 | 3.62 | 4.36 | 3.54 | 1.21 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- −10%
- TTM
- 27%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 11%
- TTM
- 6%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 11%
- 3 Years
- 16%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Prices are delayed and for information only. Nothing on this page is investment advice.